Cargando…

Changes in antihypertensive treatment in surviving patients SARS-CoV-2 respiratory infection and its cardiovascular impact after one year of follow-up()

Detalles Bibliográficos
Autores principales:	Águila Gordo, Daniel, Martínez del Rio, Jorge, Piqueras Flores, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801868/ https://www.ncbi.nlm.nih.gov/pubmed/35128062 http://dx.doi.org/10.1016/j.medcle.2021.06.007

Ejemplares similares

Cambios en el tratamiento antihipertensivo de pacientes supervivientes a infección respiratoria por SARS-CoV-2 y su repercusión cardiovascular tras un año de seguimiento
por: Águila Gordo, Daniel, et al.
Publicado: (2022)

Cardiovascular events after COVID-19 hospitalization: long-term follow-up
por: Negreira-Caamaño, Martín, et al.
Publicado: (2022)

Enfermedad cardiovascular tras infección por SARS-CoV-2 en pacientes ancianos. Resultados del seguimiento anual de una cohorte de supervivientes
por: Águila-Gordo, Daniel, et al.
Publicado: (2022)

Eventos cardiovasculares tras la hospitalización por COVID-19: seguimiento a largo plazo
por: Negreira-Caamaño, Martín, et al.
Publicado: (2022)

Administration of ACEI or ARB in chronic kidney disease patients with concomitant SARS-CoV-2 respiratory infection()
por: Mateo Gómez, Cristina, et al.
Publicado: (2021)

Comparative analysis between the use of renin–angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection()
por: Martínez-del Río, Jorge, et al.
Publicado: (2020)

Uso de IECA o ARA-II en pacientes con enfermedad renal crónica e infección respiratoria por SARS-CoV-2
por: Mateo Gómez, Cristina, et al.
Publicado: (2021)

Mortalidad y factores pronósticos asociados en pacientes ancianos y muy ancianos hospitalizados con infección respiratoria COVID-19
por: Águila-Gordo, Daniel, et al.
Publicado: (2021)

Análisis de la relación entre los inhibidores del sistema renina-angiotensina y la evolución de pacientes hospitalizados por infección respiratoria COVID-19
por: Martínez-del Río, Jorge, et al.
Publicado: (2020)

Impact of Treatment with Renin–Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19
por: Negreira-Caamaño, Martin, et al.
Publicado: (2020)

Antihypertensives and their relation to mortality by SARS‐CoV‐2 infection
por: Singh, Sandeep, et al.
Publicado: (2021)

Acute myelitis and SARS-CoV-2 infection. A new etiology of myelitis?
por: Águila-Gordo, Daniel, et al.
Publicado: (2020)

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
por: Basile, J N
Publicado: (2009)

Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain
por: Del Águila-Mejía, Javier, et al.
Publicado: (2022)

SARS-CoV-2 and the sympathetic immune response: Dampening inflammation with antihypertensive drugs (Clonidine and Propranolol)
por: Hyoju, Sanjiv K, et al.
Publicado: (2020)

An Artificial Placenta Experimental System in Sheep: Critical Issues for Successful Transition and Survival up to One Week
por: Eixarch, Elisenda, et al.
Publicado: (2023)

CARDIOVASCULAR IMPAIRMENT IN LONG COVID ONE YEAR POST-SARS-COV-2 INFECTION
por: Roca-Fernandez, Adriana, et al.
Publicado: (2022)

Ventilation support in SARS-CoV-2 pneumonia. Strategy and indications
por: Gordo, Federico, et al.
Publicado: (2022)

One-year Follow-up after Severe SARS-CoV-2 Pneumonia
por: Tang, Lei, et al.
Publicado: (2021)

Antihypertensive, antidyslipidemic, and renoprotective effects of Bursera simaruba on metabolic syndrome
por: Alejandrina Guzmán Hernández, Elizabeth, et al.
Publicado: (2023)

Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
por: Zamorano, José, et al.
Publicado: (2011)

Racial Differences in Response to Antihypertensive Therapy: Does One Size Fits All?
por: Gupta, Ajay K
Publicado: (2010)

How Dexamethasone Used in Anti-COVID-19 Therapy Influenced Antihypertensive Treatment in Patients with SARS-CoV-2
por: Cârstea, Andrei Puiu, et al.
Publicado: (2023)

RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment
por: Lynch, Amy I, et al.
Publicado: (2012)

Early adherence to antihypertensive drugs and long‐term cardiovascular mortality in the “real world”
por: Salazar, Martin R.
Publicado: (2021)

The correlation between different antihypertensive treatments and prognosis of cardiovascular disease in hypertensive patients
por: Liu, Shengnan, et al.
Publicado: (2023)

Antihypertensive medication classes and the risk of dementia over a decade of follow-up
por: Schroevers, Jakob L., et al.
Publicado: (2023)

SARS-CoV-2 reliably detected in frozen saliva samples stored up to one year
por: Frediani, Jennifer K., et al.
Publicado: (2022)

Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells
por: Iwanski, Jessika, et al.
Publicado: (2021)

Antihypertensive medication and outcome in patients with COVID-19 compared to non-COVID respiratory infections
por: Blum, S, et al.
Publicado: (2021)

High Inequalities Associated With Socioeconomic Deprivation in Cardiovascular Disease Burden and Antihypertensive Medication in Hungary
por: Boruzs, Klára, et al.
Publicado: (2018)

Antihypertensive Treatment With β‐Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events
por: Bang, Casper N., et al.
Publicado: (2017)

Antihypertensive effects of astaxanthin
por: Yanai, Hidekatsu, et al.
Publicado: (2008)

Plants Used as Antihypertensive
por: Verma, Tarawanti, et al.
Publicado: (2020)

Antihypertensive constituents in Sanoshashinto
por: Wu, Jianbo, et al.
Publicado: (2020)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
por: Carlos-Escalante, José A., et al.
Publicado: (2021)

Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection
por: Tsai, Sheng Feng, et al.
Publicado: (2021)

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells
por: Pires de Souza, Gabriel Augusto, et al.
Publicado: (2021)

Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein
por: Moschovou, Kalliopi, et al.
Publicado: (2023)

Evaluation of the lockdowns for the SARS-CoV-2 epidemic in Italy and Spain after one month follow up
por: Tobías, Aurelio
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mubtv0nms2eqi09ngcpp1te2ft